Login / Signup

A comprehensive look at explicit screening tools for potentially inappropriate medication: A systematic scoping review.

Geovana SchiavoMarcela ForgeriniRosa Camila LucchettaPatrícia de Carvalho Mastroianni
Published in: Australasian journal on ageing (2022)
The next stages in the development of explicit screening tools to identify PIMs include achieving more consensus between them and improving their applicability across countries. Further, it is recommended that tools include PIMs risks and advice on therapeutic alternatives.
Keyphrases
  • emergency department
  • human health
  • risk assessment
  • clinical practice
  • adverse drug